APPs provide an in-depth look at amivantamab plus lazertinib for the treatment of patients with locally advanced or metastatic non–small cell lung cancer.
Margaret Colleton, MMS, MSW, PA-C
Advertisement
Articles by Margaret Colleton, MMS, MSW, PA-C
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Oncology Nursing News
1
Managing Acute and Late Adverse Effects of Breast Cancer Radiation
2
An NP’s Perspective: Supporting Derm Toxicities in Breast Cancer as a Team
3
NGS Streamlines Biomarker Testing in Solid Tumors
4
Osimertinib/Chemo Boosts OS in EGFR+ NSCLC With Poor Prognosis
5
